Randomized double-blind, placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS) (CROSBI ID 738890)
Prilog sa skupa u časopisu | izvorni znanstveni rad
Podaci o odgovornosti
Reiner, Ž. ; Bergovec, M. ; Gjurašin, M. ; Goldner, V. ; Halle, J. ; Kranjčević, S. ; Mihatov, Š. ; Zrnić, T. ; Čulig, J. ; Tedeschi-Reiner, E.
engleski
Randomized double-blind, placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS)
However, the observed distribuion of ACVE speaks in favor of the proposed hypothesis that Chlamidia pneumoniae positive patients have a higher risk of recurrent cardiovascular events.
Randomized double-blind; placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS)
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
28-x.
2000.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Atherosclerosis (Amsterdam)
0021-9150
Podaci o skupu
Nepoznat skup
ostalo
29.02.1904-29.02.2096
Povezanost rada
Kliničke medicinske znanosti
